Onesource Specialty Pharma Limited has informed the Exchange about Investor Presentation
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma has informed the stock exchanges that the audio/video recording of its Q4 FY25 earnings call, held on May 6, 2025, is now available on the company's website. This is a routine compliance disclosure under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). The filing was signed by the Company Secretary, Trisha A. No specific financial numbers or guidance are included in this intimation; investors need to listen to the recording for details.
No direct impact on the stock price. Investors seeking insights into Q4 FY25 results and forward-looking commentary should review the earnings call recording for management guidance on margins, growth, and strategy.